Weighted Average Number of Shares Outstanding, Diluted of Immunocore Holdings plc from 31 Dec 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Immunocore Holdings plc quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Dec 2021 to 31 Dec 2025.
  • Immunocore Holdings plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 50,345,666, a 0.71% increase year-over-year.
  • Immunocore Holdings plc annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 50,345,666, a 0.71% increase from 2024.
  • Immunocore Holdings plc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 49,991,064, a 2.3% increase from 2023.
  • Immunocore Holdings plc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 48,888,975, a 6.9% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Immunocore Holdings plc Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 50,345,666 +354,602 +0.71% 01 Oct 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 50,403,717 -2,404,717 -4.6% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 50,294,205 +280,119 +0.56% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 51,949,798 +2,072,580 +4.2% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 49,991,064 +1,102,089 +2.3% 01 Oct 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 52,808,434 -1,350,533 -2.5% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 50,014,086 +1,320,039 +2.7% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 49,877,218 +1,693,447 +3.5% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 48,888,975 01 Oct 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
Q3 2023 54,158,967 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 48,694,047 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 48,183,771 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1

Immunocore Holdings plc Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 50,345,666 +354,602 +0.71% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 49,991,064 +1,102,089 +2.3% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 48,888,975 +3,174,052 +6.9% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 45,714,923 +3,226,344 +7.6% 01 Jan 2022 31 Dec 2022 10-K 26 Feb 2025 2024 FY
2021 42,488,579 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.